Salivary Testosterone in Men: Diurnal Variation and Post-Prandial Responses
NCT04326673 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2025-01-06
Summary
The purpose is to evaluate Sal-T against standard biomarkers of male gonadal status based on serum T, calculated free T and BAT. The optimal salivary sampling in terms of fasting and time of day will also be defined.
The ultimate aim is to add Sal-T into the Trust's repertoire of tests in investigating suspected hypogonadism in men.
Conditions
- Hypogonadism, Male
Interventions
- OTHER
-
Testosterone Measurements in healthy volunteers after fasting
salivary testosterone measurements taken in morning and evening and a single blood test for testosterone taken
- OTHER
-
Testosterone Measurements after glucose loading
salivary tstosterone and blood testosterone measurements
Sponsors & Collaborators
-
The Royal Wolverhampton Hospitals NHS Trust
lead OTHER_GOV
Principal Investigators
-
R Gama · The Royal Wolverhampton NHS Trust
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-10-30
- Primary Completion
- 2023-10-30
- Completion
- 2023-10-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
NCT04456296 ·Status: COMPLETED ·Phase: PHASE4
-
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
NCT05773183 ·Status: UNKNOWN
-
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00431197 ·Status: COMPLETED ·Phase: PHASE1
-
Diagnostic Relevance of Salivary Testosterone Concentrations in Doping Control.
NCT02134470 ·Status: UNKNOWN ·Phase: NA
-
Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males
NCT03541395 ·Status: COMPLETED ·Phase: NA
-
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
NCT00161421 ·Status: COMPLETED ·Phase: PHASE2
-
EndogenousTestosterone Response to a Testosterone Boosting Supplement
NCT02600650 ·Status: UNKNOWN ·Phase: NA
-
Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects
NCT01813201 ·Status: COMPLETED ·Phase: PHASE4
-
BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPC
NCT05530395 ·Status: NOT_YET_RECRUITING
-
A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone
NCT00522431 ·Status: COMPLETED ·Phase: PHASE3
-
Survey of Testosterone Levels in Male Cancer Patients
NCT00483418 ·Status: COMPLETED
-
Testosterone Treatment for Hypogonadal Men
NCT00433199 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Pharmacokinetics and Safety of Testosterone
NCT01370369 ·Status: COMPLETED ·Phase: PHASE2
-
Does Testosterone Improve Function in Hypogonadal Older Men
NCT00304213 ·Status: WITHDRAWN ·Phase: PHASE4
-
Testosterone Improves Exercise Oxygen Uptake, Insulin Resistance and Muscle Strength in Elderly Patients With Chronic Heart Failure
NCT00512408 ·Status: TERMINATED
-
Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men
NCT00365794 ·Status: COMPLETED ·Phase: PHASE2
-
ORAL T-6: Oral Androgens in Man-6
NCT00663793 ·Status: COMPLETED ·Phase: PHASE1
-
Phlebotomy Study of Testosterone Undecanoate
NCT02670343 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetic Evaluation of Testosterone Gel (1%)
NCT00193700 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%
NCT02667561 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of The Effects of Testosterone in Frail Elderly Men
NCT00190060 ·Status: COMPLETED ·Phase: PHASE4
-
Oral T7 Oral Testosterone in Man
NCT00842751 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Testosterone Replacement on Insulin Resistance
NCT00487734 ·Status: COMPLETED ·Phase: PHASE4
-
Calciotropic Effects After HCG Stimulation Test
NCT03254641 ·Status: COMPLETED
-
Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene Citrate
NCT05096169 ·Status: WITHDRAWN ·Phase: PHASE2